This Clinical Reference Group (CRG) covers infectious disease services. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans.
- Dr. Mathias Schmid, Chair
- Dr. Brian Angus, Clinical Member
- Dr. Michael Brown, Clinical Member
- Dr. Patrick Lillie, Clinical Member
- Dr. Nicholas Price, Clinical Member
- Dr. Michael Beadsworth, Clinical Member
- Dr. Robert Porter, Clinical Member
- Dr. Neil Jenkins, Clinical Member
- Dr. Annette Wood, PHE Lead
- Emily Lam, Patient & Public Voice Representative
- June Fenton, Patient & Public Voice Representative
- Martin Llewelyn, Affiliate Member – BIA
- Sharon Hodgson, Lead Commissioner
A key part of the CRG’s work is the delivery of the ‘products’ of commissioning. These are the tools used by the 10 Hub Commissioning Teams to contract services on an annual basis.
Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe both core and developmental service standards. Core standards are those that all funded providers should be able to demonstrate, with developmental standards being those which may require further changes in practice over time to provide excellence in the field.
The following service specifications fall within the scope of this CRG:
- Airborne high consequence infectious diseases service specification (adults)
- Airborne high consequence infectious diseases service specification (children)
- Operational Delivery Networks for Hepatitis C Care in Adults
- Specialised Services for Infectious Diseases (Adult)
- High Secure Infectious Diseases Unit (All Ages)
- Tropical Medicine (All Ages)
- Human T-Cell Lymphotropic Virus Type 1 and 2 (All Ages)
- Bone and Joint Infections (Adult)
A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, a commissioning policy as appropriate. These are important documents that are developed to ensure consistency in access to treatments nationwide.
The following policies fall within the scope of this CRG:
Policy statements are brief documents that define the current commissioning position to support service contracting.
The following policy statements fall within the scope of this CRG:
- Antivirals for adults with recent onset (acute) hepatitis C
- Retreatment of Chronic Hepatitis C infection in adults with advanced or decompensated cirrhosis
- Treatment of chronic Hepatitis C in patients with cirrhosis – Clinical Commissioning Policy Statement
- List of Hepatitis C Operational Delivery Networks in England
- Use of therapeutic immunoglobulin in England